Patent · US Active

Triazole oxadiazoles derivatives

US8202856B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2008
Grant dateJun 19, 2012
Priority date—
Expiry dateDec 30, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of formula I:wherein R1, R2,Ra, Rb, X have the meanings given in claim 16. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.